Yale — New Haven, Connecticut

Public research footprint of Yale, compiled from the ClinicalTrials.gov public registry.

4,173

Registered studies

1,289

Active

711

Recruiting now

2,263

Completed

539

Stopped or withdrawn

Most-studied conditions

Lung Non-Small Cell Carcinoma · Anatomic Stage II Breast Cancer AJCC v8 · Acute Myeloid Leukemia Arising From Previous… · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recently updated registry entries

NCT07104032 — IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07215910 — Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Yale?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.